Showing 101,861 - 101,880 results of 113,076 for search '(( 12 we decrease ) OR ( 5 ((((point decrease) OR (fold decrease))) OR (a decrease)) ))', query time: 1.31s Refine Results
  1. 101861

    DataSheet3_Effects of Huang-Lian-Jie-Du decoction on improving skin barrier function and modulating T helper cell differentiation in 1-chloro-2,4-dinitrobenzene-induced atopic derm... by Huiyuan Zhang (66646)

    Published 2024
    “…</p><p>Results: HLJDD showcased a substantial amelioration in skin through the upregulation of FLG, LOR, AQP3, and reducing scratching behaviors in AD-like mice, Also, the quantity of infiltrated mast cells (MCs), pruritus-related mRNA were decreased. …”
  2. 101862

    DataSheet1_Effects of Huang-Lian-Jie-Du decoction on improving skin barrier function and modulating T helper cell differentiation in 1-chloro-2,4-dinitrobenzene-induced atopic derm... by Huiyuan Zhang (66646)

    Published 2024
    “…</p><p>Results: HLJDD showcased a substantial amelioration in skin through the upregulation of FLG, LOR, AQP3, and reducing scratching behaviors in AD-like mice, Also, the quantity of infiltrated mast cells (MCs), pruritus-related mRNA were decreased. …”
  3. 101863

    DataSheet2_Effects of Huang-Lian-Jie-Du decoction on improving skin barrier function and modulating T helper cell differentiation in 1-chloro-2,4-dinitrobenzene-induced atopic derm... by Huiyuan Zhang (66646)

    Published 2024
    “…</p><p>Results: HLJDD showcased a substantial amelioration in skin through the upregulation of FLG, LOR, AQP3, and reducing scratching behaviors in AD-like mice, Also, the quantity of infiltrated mast cells (MCs), pruritus-related mRNA were decreased. …”
  4. 101864

    <b>Association of Hypoglycemia With the Time to Dextrose in Treatment of Diabetes-Related Ketoacidosis</b> by Anthony S. Walls (22127698)

    Published 2025
    “…It found that patients are at increased risk for hypoglycemia during the active treatment window of DKA, as well as during the entire hospitalization, when the addition of dextrose or glucose is delayed. Key Points · During the treatment of diabetes-related ketoacidosis (DKA), a delay of more than 30 minutes in adding i.v. dextrose or oral glucose after blood glucose levels have decreased sufficiently is associated with greater risk of hypoglycemia. · Limiting the time delay in starting dextrose or glucose to ≤30 minutes after a patient’s blood glucose is <250 mg/dL may help prevent hypoglycemia episodes.…”
  5. 101865

    Machine learning-based management of electric vehicles charging: Towards highly-dispersed fast chargers by Shibl, M.

    Published 2020
    “…Additionally, LSTM was also the model with the smallest error rate, at a value of ±0.7%, followed by RF, DT, KNN, SVM, DNN, and NB. …”
    Get full text
    Get full text
  6. 101866

    Ratings of perceived exertion misclassify intensities for sedentary older adults during graded cycling test: Effect of supramaximal high-intensity interval training by Jabbour G.

    Published 2018
    “…Two healthy groups of 17 young adults [average (SD) age: 26.2 (2.4) year] and 13 older adults [average (SD) age: 54.5 (2.3) year] completed a 6-week SCE intervention on an ergocycle. …”
    Get full text
    Get full text
  7. 101867

    Image3_Modulation of the biological network of lumbar spinal stenosis by Tongdu Huoxue Decoction based on clinical metabolomics.TIF by Luhong Ji (14819746)

    Published 2023
    “…Regarding metabolomics, the levels of 41 differential metabolites were significantly different in the normal group (group NC) compared to group A, and those were significantly restored after treatment with THD, including chenodeoxycholic acid 3-sulfate, taurohyodeoxycholic acid, 3,5-Dihydroxy-4-methoxybenzoic acid, pinocembrin. …”
  8. 101868

    <i>Cited1</i> Deficiency Suppresses Intestinal Tumorigenesis by Valérie Méniel (440547)

    Published 2013
    “…<i>Cited1</i> deficiency decreases intestinal tumourigenesis in <i>Apc<sup>Min/+</sup></i> mice and impacts upon a number of oncogenic signaling pathways, including Wnt. …”
  9. 101869

    Table_3_Transcriptional changes in the gilthead seabream (Sparus aurata) skin in response to ultraviolet B radiation exposure.xlsx by Ricardo N. Alves (8839895)

    Published 2022
    “…S. aurata juveniles were exposed for 43 days to two experimental groups: 1) UVB (daily dose, 6 kJ m<sup>-2</sup>; representing levels between 5 and 7 m depth); 2) Unirradiated treatment, used as a control. …”
  10. 101870

    Comparison of PfRH1 expression in merozoite of W2mef and W2mef (switched). by Xiaohong Gao (50514)

    Published 2008
    “…(B) Enriched culture supernatant from W2mef and W2mef (switched) parasite were probed with αrRII-3 and αSERA5. There was higher decreased in RH1 expression level in W2mef (switched) parasites. …”
  11. 101871

    Evaluation of the xanthine-xanthine oxidase (X-XO) system and the impact of antioxidants on sperm viability, ROS and motility. by Mary Hagedorn (319120)

    Published 2013
    “…(<b>C</b>) Increased stress was correlated with decreased sperm motility that was mitigated by X-XO + CAT (P>0.05), but not by X-XO + SOD or X-XO + vitamin E (P<0.05; ANOVA and Tukey’s Multiple Comparison test, F = 39.5). …”
  12. 101872

    p62/SQSTM1 knockdown had little effect on the Nrf2-NQO1 pathway in oral cancer cells. by Takuma Inui (330849)

    Published 2013
    “…<p>However, p62/SQSTM1 knockdown affected the growth of the cells. (A) p62/SQSTM1 was abundantly expressed in SAS and CAL27 oral cancer cells. …”
  13. 101873

    Influence of Glass Composition on the Luminescence Mechanisms of CdSe Quantum-Dot-Doped Glasses by Wenke Li (1702348)

    Published 2021
    “…In this work, we characterized the electronic structure of CdSe quantum dots embedded in a series of <i>x</i> Na<sub>2</sub>O, (1–<i>x</i>) SiO<sub>2</sub> glass matrices (<i>x</i> = 0, 0.25, 0.33, and 0.5). …”
  14. 101874

    Gonococci invasion of human macrophages is independent of CEACAM1. by Stanimir S. Ivanov (3394922)

    Published 2021
    “…<p><b>(A)</b> qPCR mRNA analysis for <i>ceacam1</i>, <i>ceacam3</i>, <i>ceacam5</i> and <i>ceacam6</i> was carried out on U937 MFs that were either infected with <i>N</i>.…”
  15. 101875

    Image_1_Oxygen Variability During ENSO in the Tropical South Eastern Pacific.JPEG by Dante Espinoza-Morriberón (6235361)

    Published 2019
    “…The passage of intense remotely forced coastal trapped waves caused a strong deepening (shoaling) of the OMZ upper limit during EN (LN). …”
  16. 101876
  17. 101877

    Effect of IL-10 receptor (IL-10R) blockade upon leukomyelitis in Theiler’s murine encephalomyelitis virus (TMEV)-infected SJL mice. by Ann-Kathrin Uhde (3110976)

    Published 2016
    “…A,B: immunohistochemistry, bar = 20 μm. (C) Statistical analyses revealed a significant increase of CD3<sup>+</sup> T cells in TMEV-infected mice with IL-10R blockade compared to isotype-treated animals at 49 dpi. …”
  18. 101878

    Fst inhibits pSmad, P63 and K14. by Na Liu (102929)

    Published 2019
    “…<p>(A) Relative expression levels by qPCR of <i>Fst</i> during differentiation of WT ES cells stably overexpressing <i>Fst</i> (OE), compared with WT ES cells transfected with empty vector served as controls (Con). …”
  19. 101879

    Table_1_Transcriptional changes in the gilthead seabream (Sparus aurata) skin in response to ultraviolet B radiation exposure.xlsx by Ricardo N. Alves (8839895)

    Published 2022
    “…S. aurata juveniles were exposed for 43 days to two experimental groups: 1) UVB (daily dose, 6 kJ m<sup>-2</sup>; representing levels between 5 and 7 m depth); 2) Unirradiated treatment, used as a control. …”
  20. 101880

    ISCALIMAB-KAHALY-SUPPLEMENTAL by George Kahaly (5894963)

    Published 2019
    “…</p> <p><b>Objective</b> Evaluate efficacy and safety of a human, blocking, non-depleting anti-CD40 monoclonal antibody, iscalimab, in hyperthyroid patients with GD</p> <p><b>Design</b> Open label, phase II proof-of-concept study</p> <p><b>Setting </b>Multicenter</p> <p><b>Patients </b>Fifteen with GD</p> <p><b>Intervention</b> Patients received five doses of iscalimab at 10 mg/kg intravenously over 12 weeks.…”